Canaccord Genuity Maintains Hold on Merit Medical Systems, Lowers Price Target to $70
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity analyst William Plovanic maintains a 'Hold' rating on Merit Medical Systems (NASDAQ:MMSI) and lowers the price target from $86 to $70.
August 28, 2023 | 1:59 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Canaccord Genuity has maintained a 'Hold' rating on Merit Medical Systems and lowered the price target from $86 to $70.
The lowering of the price target by Canaccord Genuity from $86 to $70 indicates a potential downside for the stock. This could lead to a negative sentiment among investors, potentially impacting the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100